2009•Journal of Medicinal ChemistryRequires access
Structure−Activity Study of Pentamidine Analogues as Antiprotozoal Agents
Svetlana M. Bakunova, Stanislav A. Bakunov, Donald A. Patrick, E. V. K. Suresh Kumar, Kwasi A. Ohemeng, Arlene S. Bridges, Tanja Wenzler, Todd Barszcz, Susan Jones, Karl A. Werbovetz, Reto Brun, Richard R. Tidwell
Open publisher page 58 citations
Abstract
Diamidine 1 (pentamidine) and 65 analogues (2-66) have been tested for in vitro antiprotozoal activities against Trypanosoma brucei rhodesiense, Plasmodium falciparum, and Leishmania donovani, and for cytotoxicity against mammalian cells. Dications 32, 64, and 66 exhibited antitrypanosomal potencies equal or greater than melarsoprol (IC(50) = 4 nM). Nine congeners (2-4, 12, 27, 30, and 64-66) were more active against P. falciparum than artemisinin (IC(50) = 6 nM). Eight compounds (12, 32, 33, 44, 59, 62, 64, and 66) exhibited equal or better antileishmanial activities than 1 (IC(50) = 1.8 microM). Several congeners were more active than 1 in vivo, curing at least 2/4 infected animals in the acute mouse model of trypanosomiasis. The diimidazoline 66 was the most promising compound in the series, showing excellent in vitro activities and high selectivities against T. b. rhodesiense, P. falciparum, and L. donovani combined with high antitrypanosomal efficacy in vivo.